ZERONA™ Laser

• Lose up to 9 inches in just two weeks.
• Reveal your true shape.
• Look better. Feel Better. Live better.
• Reduce stubborn fat from your tummy, back, hips, thighs, buttocks, love handles, arms, chin, and neck.
• Drop 2 to 7 pant/dress sizes

Call/email for pricing and to book your Zerona consultation                  
619-235-6865 appointments@sentebellaspa.com

 

FDA Approves Erchonia’s Zerona Laser

Dr. Sarosy provides cutting-edge body Contouring treatment in Downtown

 San Diego

 

San Diego, CA – September 24th 2010 –Sente Bella Day Spa today announces that Erchonia’s Zerona laser has been granted market clearance by the U.S. Food and Drug Administration. The Zerona is the first non-invasive aesthetic device to receive FDA market clearance in the U.S. for circumferential reduction of the waist, hips, and thighs.  

 

Available at Sente Bella Day Spa in San Diego the Zerona emits a low-level, or cold, output energy that generates no thermal effect on the body’s tissue eliminating any risk to the patient. Zerona has been clinically proven to target fat cells causing their immediate collapse thereby significantly reducing body volume. Through a natural process of fat removal, the laser-released fat is safely removed and broken down, providing patients with a truly non-invasive procedure without side effects or downtime. 

 

“Zerona is scientifically-proven to be both safe and effective, and this most recent FDA clearance simply validates the experience we’ve had with Zerona at our practice,” says Dr.Sarosy. “Zerona is an excellent choice for those who want to lose a few inches but don’t want to go through something invasive. The results speak for themselves.”

 

The exciting part of this approval from the FDA is the long-awaited new classification of "Low Level Laser Therapy for Aesthetic Use" which is the result of the rigorous clinical research on this device. The FDA granted market clearance following the completion of a placebo-controlled, randomized, double-blind, multi-site clinical investigation evaluating sixty-seven study participants. The results obtained from that study demonstrated an average inch loss reduction of 3.65 inches across patient’s waist, hips, and thighs in two weeks. The clinical trial, absent of diet restrictions, exercise requirements, or any other adjunctive components properly illustrated the clinical utility of the Zerona and set the precedent on how aesthetic devices should be evaluated. 

 

For more information or to book a Zerona consultation,

please call 619-235-6865

 

 

About Erchonia

Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years Erchonia has been conducting research & development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven to be safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit www.erchonia.com.

 

About SBMI

SBMI is dedicated to bringing clinically proven, innovative health and wellness products that are safe and effective to market. SBMI is the exclusive North American distributor of Zerona® the only clinically proven, non-invasive body slimming device on the market, as well as the Erchonia EML, the only laser device FDA approved for pain during liposuction and breast surgery.  For more information, visit www.SBMI.com.